Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS

Neurology

Volumn 66, Issue 12, 2006, Pages 1929-1931

  Fernandez Santiago R ^a,b   Sharma, M ^a   Mueller, J C ^a,c   Gohlke, H ^d   Illig, T ^d   Anneser, J ^e   Munch C ^f   Ludolph, A ^f   Kamm, C ^a   Gasser, T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

5' UNTRANSLATED REGION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; GENETIC RISK; GERMANY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SEX RATIO; STATISTICAL SIGNIFICANCE;

AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERMANY; HETEROZYGOTE; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STATISTICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745890898     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000219756.71928.25     Document Type: Article

References (10)

1. Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet 2003;63:83-101.
2. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-749.
3. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-394.
4. Illig T, Bongardt F, Schöpfer A, et al. The endotoxin receptor TLR 4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 2003;52:2861-2864.
5. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-1249.
6. Barrett JC, Fry B, Maller J, Daily MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
7. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-1261.
8. Zheng C, Nennesmo I, Fadeel B, Henter JI. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2004;56:564-567.
9. Greenway MJ, Alexander MD, Ennis S, et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004;63:1936-1938.
10. Del Bo R, Scarlato M, Ghezzi S, et al. Vascular endothelial growth factor variability is associated with increased risk for AD. Ann Neurol 2005;57:373-380.